Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website http://www.jocmr.org

Original Article

Volume 10, Number 2, February 2018, pages 82-87


Frailty Testing Pilot Study: Pros and Pitfalls

Tables

Table 1. Number of Patients Tested, Completeness of Testing, and Number of Frail Patients in the Three Testing Phases
 
CohortPatients testedTesting completedFrailInconclusive for frailty
20156464 (100%)14 (15.6%)0 (0%)
20164035 (87.5%)8 (20%)0 (0%)
20172813 (46%)1 (3.5%)4 (14.3%)

 

Table 2. Prevalence of Frailty Criteria Among Tested Patients
 
Frailty factors occurrencesShrinkingExhaustionLow physical actSlow walkingGrip strength
*P < 0.05 by Chi-squared.
Present (total, 128)15 (11.7%)48 (37.5%)38 (29.6%)30 (23.4%)44 (34.3%)
Present in frail (23 patients)6 (26%)*19 (82.6%)*18 (78.2%)*14 (60.8%)*17 (73.9%)*
Present in non-frail (105 patients)9 (8.5%)29 (27.6%)20 (19.0%)16 (15.2%)27 (25.7%)

 

Table 3. Evaluation Status of Patients Who Underwent Frailty Testing
 
After first evaluationTotal (127)Not frail (104)Frail (23)
*P < 0.05 by Chi-squared.
Not a candidate11 (8.6%)7 (6.7%)4 (17.4%)
Died in evaluation4 (3.1%)2 (1.9%)2 (8.6%)
Remains in evaluation45 (35.4%)35 (33.6%)10 (43.4%)
Listed67 (52.7%)60 (57.6%)7 (30.4%)*

 

Table 4. Transplant Status of Patients Frailty Tested After Listing for Transplant
 
After listingTotal (67)Not frail (60)Frail (7)
Died on list2 (2.9%)2 (3.3%)0 (0%)
Transplanted25 (37.3)22 (36.6%)3 (42.8%)
Deceased donor transplant11 (44%)11 (50%)0 (0%)
Living donor transplant14 (56%)11 (50%)3 (100%)